These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19274094)

  • 1. SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines.
    Egesten A; Olin AI; Linge HM; Yadav M; Mörgelin M; Karlsson A; Collin M
    PLoS One; 2009; 4(3):e4769. PubMed ID: 19274094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes.
    Egesten A; Eliasson M; Johansson HM; Olin AI; Morgelin M; Mueller A; Pease JE; Frick IM; Bjorck L
    J Infect Dis; 2007 Mar; 195(5):684-93. PubMed ID: 17262710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibacterial chemokine MIG/CXCL9 is constitutively expressed in epithelial cells of the male urogenital tract and is present in seminal plasma.
    Linge HM; Collin M; Giwercman A; Malm J; Bjartell A; Egesten A
    J Interferon Cytokine Res; 2008 Mar; 28(3):191-6. PubMed ID: 18338951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
    Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
    J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-γ in experimental dry eye.
    Coursey TG; Bohat R; Barbosa FL; Pflugfelder SC; de Paiva CS
    J Immunol; 2014 Nov; 193(10):5264-72. PubMed ID: 25288568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines profiling of patients with preterm birth.
    Laudanski P; Lemancewicz A; Kuc P; Charkiewicz K; Ramotowska B; Kretowska M; Jasinska E; Raba G; Karwasik-Kajszczarek K; Kraczkowski J; Laudanski T
    Mediators Inflamm; 2014; 2014():185758. PubMed ID: 24876667
    [TBL] [Abstract][Full Text] [Related]  

    Semenov AV; Arsentieva NA; Lubimova NE; Tulienev SV; Basina VV; Esaulenko EV; Totolyan AA
    Klin Lab Diagn; 2015 Aug; 60(8):45-51. PubMed ID: 26596048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
    Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
    Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous abortion is associated with differentially expressed angiogenic chemokines in placenta and decidua.
    Spathakis M; Filidou E; Pappa C; Arzou BC; Georgiadis A; Kontomanolis EN; Nikolettos N; Kolios G; Galazios G; Arvanitidis K
    Arch Gynecol Obstet; 2023 Sep; 308(3):821-830. PubMed ID: 35997970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydophila pneumoniae induces production of the defensin-like MIG/CXCL9, which has in vitro antichlamydial activity.
    Balogh EP; Faludi I; Virók DP; Endrész V; Burián K
    Int J Med Microbiol; 2011 Mar; 301(3):252-9. PubMed ID: 21056004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
    Müller M; Carter S; Hofer MJ; Campbell IL
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
    Callahan V; Hawks S; Crawford MA; Lehman CW; Morrison HA; Ivester HM; Akhrymuk I; Boghdeh N; Flor R; Finkielstein CV; Allen IC; Weger-Lucarelli J; Duggal N; Hughes MA; Kehn-Hall K
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34205098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
    Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
    Ahuja SK; Murphy PM
    J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.
    Crawford MA; Burdick MD; Glomski IJ; Boyer AE; Barr JR; Mehrad B; Strieter RM; Hughes MA
    PLoS Pathog; 2010 Nov; 6(11):e1001199. PubMed ID: 21124994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation.
    Flier J; Boorsma DM; van Beek PJ; Nieboer C; Stoof TJ; Willemze R; Tensen CP
    J Pathol; 2001 Aug; 194(4):398-405. PubMed ID: 11523046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.
    Nishioka Y; Manabe K; Kishi J; Wang W; Inayama M; Azuma M; Sone S
    Clin Exp Immunol; 2007 Aug; 149(2):317-26. PubMed ID: 17550373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.
    Loetscher M; Gerber B; Loetscher P; Jones SA; Piali L; Clark-Lewis I; Baggiolini M; Moser B
    J Exp Med; 1996 Sep; 184(3):963-9. PubMed ID: 9064356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I-TAC is a dominant chemokine in controlling skin intragraft inflammation via recruiting CXCR3+ cells into the graft.
    Li B; Xu W; Xu L; Jiang Z; Wen Z; Li K; Xiong S
    Cell Immunol; 2010; 260(2):83-91. PubMed ID: 19875106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
    Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
    Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.